TY - JOUR
T1 - Gene-specific ACMG/AMP classification criteria for germline APC variants
T2 - recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer / Polyposis Variant Curation Expert Panel
AU - Spier, Isabel
AU - Yin, Xiaoyu
AU - Richardson, Marcy
AU - Pineda, Marta
AU - Laner, Andreas
AU - Ritter, Deborah
AU - Boyle, Julie
AU - Mur, Pilar
AU - Hansen, Thomas V O
AU - Shi, Xuemei
AU - Mahmood, Khalid
AU - Plazzer, John-Paul
AU - Ognedal, Elisabet
AU - Nordling, Margareta
AU - Farrington, Susan M
AU - Yamamoto, Gou
AU - Baert-Desurmont, Stéphanie
AU - Martins, Alexandra
AU - Borras, Ester
AU - Tops, Carli
AU - Webb, Erica
AU - Beshay, Victoria
AU - Genuardi, Maurizio
AU - Pesaran, Tina
AU - Capellá, Gabriel
AU - Tavtigian, Sean V
AU - Latchford, Andrew
AU - Frayling, Ian M
AU - Plon, Sharon E
AU - Greenblatt, Marc
AU - Macrae, Finlay A
AU - Aretz, Stefan
AU - InSiGHT - ClinGen Hereditary Colon Cancer / Polyposis Variant Curation Expert Panel
N1 - Copyright © 2023. Published by Elsevier Inc.
PY - 2024
Y1 - 2024
N2 - PURPOSE: The Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (VCEP) was established by the International Society for Gastrointestinal Hereditary Tumours and the Clinical Genome Resource, who set out to develop recommendations for the interpretation of germline APC variants underlying Familial Adenomatous Polyposis, the most frequent hereditary polyposis syndrome.METHODS: Through a rigorous process of database analysis, literature review, and expert elicitation, the APC VCEP derived gene-specific modifications to the ACMG/AMP (American College of Medical Genetics and Genomics and Association for Molecular Pathology) variant classification guidelines and validated such criteria through the pilot classification of 58 variants.RESULTS: The APC-specific criteria represented gene- and disease-informed specifications, including a quantitative approach to allele frequency thresholds, a stepwise decision tool for truncating variants, and semiquantitative evaluations of experimental and clinical data. Using the APC-specific criteria, 47% (27/58) of pilot variants were reclassified including 14 previous variants of uncertain significance (VUS).CONCLUSION: The APC-specific ACMG/AMP criteria preserved the classification of well-characterized variants on ClinVar while substantially reducing the number of VUS by 56% (14/25). Moving forward, the APC VCEP will continue to interpret prioritized lists of VUS, the results of which will represent the most authoritative variant classification for widespread clinical use.
AB - PURPOSE: The Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (VCEP) was established by the International Society for Gastrointestinal Hereditary Tumours and the Clinical Genome Resource, who set out to develop recommendations for the interpretation of germline APC variants underlying Familial Adenomatous Polyposis, the most frequent hereditary polyposis syndrome.METHODS: Through a rigorous process of database analysis, literature review, and expert elicitation, the APC VCEP derived gene-specific modifications to the ACMG/AMP (American College of Medical Genetics and Genomics and Association for Molecular Pathology) variant classification guidelines and validated such criteria through the pilot classification of 58 variants.RESULTS: The APC-specific criteria represented gene- and disease-informed specifications, including a quantitative approach to allele frequency thresholds, a stepwise decision tool for truncating variants, and semiquantitative evaluations of experimental and clinical data. Using the APC-specific criteria, 47% (27/58) of pilot variants were reclassified including 14 previous variants of uncertain significance (VUS).CONCLUSION: The APC-specific ACMG/AMP criteria preserved the classification of well-characterized variants on ClinVar while substantially reducing the number of VUS by 56% (14/25). Moving forward, the APC VCEP will continue to interpret prioritized lists of VUS, the results of which will represent the most authoritative variant classification for widespread clinical use.
UR - http://www.scopus.com/inward/record.url?scp=85179054274&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2023.100992
DO - 10.1016/j.gim.2023.100992
M3 - Journal article
C2 - 37800450
SN - 1098-3600
VL - 26
JO - Genetics in medicine : official journal of the American College of Medical Genetics
JF - Genetics in medicine : official journal of the American College of Medical Genetics
IS - 2
M1 - 100992
ER -